Different Oral Antithrombotic Therapy for the Treatment of Ventricular Thrombus: An Observational Study from 2010 to 2019

Figure 4

Cumulative event probability curve for thrombus resolution of NOACs, VKAs, and APT. Kaplan–Meier method was used to calculate the cumulative event probability of three antithrombotic agents and the time was coded in days from the date of first diagnosis of VT to the date of complete resolution of VT in patients with VT. Log-rank test was used to compare the cumulative event among groups ( < 0.0001). VT: ventricular thrombus; NOACs: non-vitamin K antagonist oral anticoagulants; VKAs: vitamin K antagonists; APT: antiplatelet therapy.